Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
3.300
-0.010 (-0.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.350
+0.050 (1.52%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $186.97 million as of April 29, 2026. Its market cap has increased by 8,264.32% in one year.
Market Cap
186.97M
Enterprise Value
169.93M
1-Year Change
8,264.32%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $186.97M, an increase of 474.18%. That is a compound annual growth rate of 50.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 187.53M | 69.82% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 196.34M |
| Karyopharm Therapeutics | 194.89M |
| MacroGenics | 193.86M |
| Cartesian Therapeutics | 187.42M |
| Korro Bio | 185.19M |
| Unicycive Therapeutics | 182.47M |
| Tonix Pharmaceuticals Holding | 182.40M |
| Acumen Pharmaceuticals | 181.98M |